Jazz Pharmaceuticals
JAZZ
#2238
Rank
A$10.39 B
Marketcap
$168.31
Share price
0.38%
Change (1 day)
-16.03%
Change (1 year)

Operating Margin for Jazz Pharmaceuticals (JAZZ)

Operating Margin as of November 2024 (TTM): 7.60%

According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 7.60%. At the end of 2023 the company had an Operating Margin of 7.77%.

Operating Margin history for Jazz Pharmaceuticals from 2005 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
20237.77%-176.28%
2022-10.19%179.35%
2021-3.65%-131.33%
202011.64%-44.62%
201921.02%-24.95%
201828.00%2.75%
201727.25%-23.84%
201635.78%8.75%
201532.91%154.65%
201412.92%-63.39%
201335.30%16.63%
201230.27%-34.06%
201145.90%143.37%
201018.86%52.09%
200912.40%-105.96%
2008-208.26%-2%
2007-212.51%22.13%
2006-174.01%-34.71%
2005-266.50%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-129.15%-1,799.34%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
0.82%-89.21%๐Ÿ‡บ๐Ÿ‡ธ USA
22.30% 193.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-3.93%-151.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.